Hainan Slashes Medical Approvals to 1.6 Days, Accelerating Global Drug Access
Hainan’s Boao Lecheng Pilot Zone now approves global medical products in 1.6 days, offering hope for rare disease patients and attracting 180+ international partners.
Rare Diseases
China Advances Rare Disease Care on 19th Rare Disease Day
China enhances rare disease care through national networks and policy reforms, offering hope to 60 million patients on Rare Disease Day 2026.
AI Breakthrough in Rare Disease Diagnosis Achieves 70% Accuracy
DeepRare AI achieves 70% diagnostic accuracy for rare diseases, cutting diagnosis times and reducing misdiagnoses, per new Nature study.
From Years to Weeks: China’s Rapid Advances in Rare Disease Diagnosis
China reduces average diagnosis time for rare diseases from four years to less than four weeks, transforming patient lives and setting new standards in global healthcare.
China Expands Medical Insurance Coverage to Combat Rare Diseases
China expands its medical insurance by adding 13 rare-disease drugs, increasing coverage and accessibility for patients across the country.
Shanghai Hosts 2024 Global Rare Diseases Research Symposium
Experts from around the world gather in Shanghai for the 2024 Global Rare Diseases Research Symposium to discuss international cooperation in rare diseases research and treatment.
2024 Global Rare Diseases Research Symposium Opens in Shanghai
Shanghai hosts the opening of the 2024 Global Rare Diseases Research Symposium, uniting experts worldwide to advance research and collaboration in addressing rare diseases.